Evidence map›Paper›PMID 38006396›Full record

ArticleAging2023

Long non-coding RNA EGOT is associated with

Ming Wang, Zhengchao Wei, Shuang Wang, Wenjuan Feng, Lihua Shang, Xiaosong Sun

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. lncRNA EGOT across cancers: TCGA analysis.Archives of medical science : AMS · 2026
    Article
  2. Article
  3. Review
  4. lncRNABiomedicines · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ming WangDepartment of Thyroid-Head and Neck Oncosurgery-1, Jilin Cancer Hospital, Changchun, Jilin Province, China.
Zhengchao WeiDepartment of Thyroid-Head and Neck Oncosurgery-1, Jilin Cancer Hospital, Changchun, Jilin Province, China.
Shuang WangDepartment of Thoracic Oncosurgery-1, Jilin Cancer Hospital, Changchun, Jilin Province, China.
Wenjuan FengDepartment of Gynecologic Oncosurgery-2, Jilin Cancer Hospital, Changchun, Jilin Province, China.
Lihua ShangDepartment of Breast Oncosurgery-2, Jilin Cancer Hospital, Changchun, Jilin Province, China.
Xiaosong SunDepartment of Thyroid-Head and Neck Oncosurgery-1, Jilin Cancer Hospital, Changchun, Jilin Province, China.
Jilin Province Tumor Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid cancer is a prevalent endocrine malignancy around the world. Radioactive

Indexed as

IodineMicroRNAsRNA, Long NoncodingThyroid NeoplasmsApoptosisCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansIodine RadioisotopesPTEN PhosphohydrolaseIodineIodine-131Iodine RadioisotopesMicroRNAsMIRN641 microRNA, humanPTEN PhosphohydrolasePTEN protein, humanRNA, Long Noncoding131I resistanceclinical functionslncRNA EGOTmiR-641PTENthyroid cancer

Identifiers

PMID38006396
PMCPMC10713430
OpenAlexW4388868391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.